SPEARHEAD CAPITAL ADVISORS, LLC – Alnylam Pharmaceuticals, Inc. Transaction History
SPEARHEAD CAPITAL ADVISORS, LLC portfolio value:
$0
portfolio value
SPEARHEAD CAPITAL ADVISORS, LLC quarter portfolio value change:
+37.24%
quarter
Alnylam Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -100.00% | -2.15K shares | -314K | $200.16 | 0 |
| Q2 2022 | share | Decrease | -1.19% | -26 shares | -41K | $145.85 | 2.15K |
| Q1 2022 | share | Decrease | -29.36% | -905 shares | -168K | $163.29 | 2.17K |
| Q4 2021 | share | Increase | +5.66% | 165 shares | -28K | $171.03 | 3.08K |
| Q3 2021 | share | Increase | +3.11% | 88 shares | 71K | $188.81 | 2.91K |
| Q2 2021 | share | Increase | +16.56% | 402 shares | 137K | $169.52 | 2.82K |
| Q1 2021 | share | Increase | +14.54% | 308 shares | 68K | $141.19 | 2.42K |
| Q4 2020 | share | Increase | +4.75% | 96 shares | -20K | $129.97 | 2.11K |
| Q3 2020 | share | Increase | +6.14% | 117 shares | 13K | $145.6 | 2.02K |
| Q2 2020 | share | Increase | 0.00% | 1.90K shares | 282K | $148.11 | 1.90K |